Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CLCSCell Source, Inc.

OTC · CIK 0001569340
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts358

Identity from submissions API

NameCell Source, Inc.
CIK0001569340
TickersCLCS
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN320379665
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone646-612-7554
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • TICKET TO SEE, INC. (2013-03-05T00:00:00.000Z → 2014-06-26T00:00:00.000Z)
Business address
57 WEST 57TH STREET
SUITE 400
NEW YORK
NY
10019
NY
Mailing address
57 WEST 57TH STREET
SUITE 400
NEW YORK
NY
10019
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

139 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-05-14 10-Q 10-Q 0001493152-26-022926 000-55413 26977146 34 5067447 1 1
2026-04-07 10-K 10-K 0001493152-26-015359 000-55413 26842481 34 18638340 1 1
2025-07-16 15-12G 15-12G 0001641172-25-019898 000-55413 251127717 34 17021
2025-06-27 8-K 8-K 4.01,9.01 0001641172-25-016833 000-55413 251083963 34 209794 1 1
2025-03-28 NT 10-K formnt10-k.htm 0001641172-25-001080 000-55413 25782162 34 36747
2024-11-14 10-Q form10-q.htm 0001493152-24-045964 000-55413 241463478 34 6700574 1 1
2024-08-19 10-Q form10-q.htm 0001493152-24-033055 000-55413 241220094 34 6391267 1 1
2024-08-14 NT 10-Q formnt10-q.htm 0001493152-24-032056 000-55413 241206324 34 35775
2024-07-29 10-Q form10-q.htm 0001493152-24-029448 000-55413 241153278 34 4301624 1 1
2024-06-24 10-K form10-k.htm 0001493152-24-024903 000-55413 241062941 34 10707934 1 1
2024-04-09 8-K form8-k.htm 8.01 0001493152-24-014035 000-55413 24831721 34 193607 1 1
2024-04-01 NT 10-K formnt10-k.htm 0001493152-24-012389 000-55413 24809569 34 40471
2023-11-09 10-Q form10-q.htm 0001493152-23-040079 000-55413 231393361 34 13841675 1 1
2023-10-06 D xslFormDX01/primary_doc.xml 06b 0001493152-23-036455 021-494016 231313034 33 8225
2023-09-19 10-Q form10-q.htm 0001493152-23-033011 000-55413 231262967 34 5022364 1 1
2023-08-23 10-Q form10-q.htm 0001493152-23-029915 000-55413 231196164 34 4094451 1 1
2023-08-15 NT 10-Q formnt10-q.htm 0001493152-23-028930 000-55413 231174244 34 36181
2023-08-08 10-K form10-k.htm 0001493152-23-027069 000-55413 231148761 34 11812436 1 1
2023-05-16 NT 10-Q formnt10-q.htm 0001493152-23-017688 000-55413 23926383 34 40069
2023-03-31 NT 10-K formnt10-k.htm 0001493152-23-009987 000-55413 23783961 34 37786
2022-12-08 10-Q form10-q.htm 0001493152-22-034876 000-55413 221452183 34 4177067 1 1
2022-12-02 10-Q form10-q.htm 0001493152-22-034255 000-55413 221441306 34 3747563 1 1
2022-11-02 10-Q form10-q.htm 0001493152-22-030233 000-55413 221355213 34 3507427 1 1
2022-07-21 8-K form8-k.htm 5.02 0001493152-22-019997 000-55413 221096861 34 194756 1 1
2022-05-12 NT 10-Q formnt10-q.htm 0001493152-22-013010 000-55413 22917577 34 36093
2022-05-06 8-K form8-k.htm 5.02 0001493152-22-012387 000-55413 22902266 34 191682 1 1
2022-04-21 3 xslF345X02/ownership.xml 0001493152-22-010598 2916
2022-04-15 10-K form10-k.htm 0001493152-22-010133 000-55413 22830591 34 11978461 1 1
2022-03-31 NT 10-K formnt10-k.htm 0001493152-22-008399 000-55413 22792039 34 33543
2022-03-11 8-K form8-k.htm 1.01,5.02 0001493152-22-006672 000-55413 22733985 34 194678 1 1
2021-11-15 10-Q form10-q.htm 0001493152-21-028675 000-55413 211411765 34 5880268 1 1
2021-08-12 10-Q form10-q.htm 0001493152-21-019491 000-55413 211167342 34 7316399 1 1
2021-08-11 4 xslF345X03/ownership.xml 0001493152-21-019296 5250
2021-07-07 4 xslF345X03/ownership.xml 0001493152-21-016323 4910
2021-07-07 4 xslF345X03/ownership.xml 0001493152-21-016322 4630
2021-07-07 4 xslF345X03/ownership.xml 0001493152-21-016320 4624
2021-07-07 4 xslF345X03/ownership.xml 0001493152-21-016319 4952
2021-06-10 4 xslF345X03/ownership.xml 0001493152-21-014007 26570
2021-06-10 4 xslF345X03/ownership.xml 0001493152-21-013992 26623
2021-06-10 SC 13D formsc-13d.htm 0001493152-21-013990 005-91841 211007651 34 179877
2021-06-10 4 xslF345X03/ownership.xml 0001493152-21-013987 7300
2021-06-10 4 xslF345X03/ownership.xml 0001493152-21-013985 12080
2021-05-17 10-Q form10-q.htm 0001493152-21-011971 000-55413 21932557 34 2197537 1
2021-04-21 SC 13D SC-13D 0001640334-21-000986 005-91841 21838976 34 146912
2021-04-20 3 FORM 3 0001640334-21-000985 6746
2021-04-15 10-K FORM 10-K 0001640334-21-000923 000-55413 21827173 34 6627969 1
2021-04-02 8-K FORM 8-K 5.02,9.01 0001640334-21-000755 000-55413 21800091 34 29246
2021-03-31 NT 10-K NT 10-K 0001640334-21-000742 000-55413 21793916 34 22738
2020-12-29 SC 13G SC 13G 0001640334-20-003161 005-91841 201421400 34 53526
2020-12-29 3 FORM 3 0001640334-20-003160 3901
2020-11-17 SC 13G SC 13G 0001640334-20-002851 005-91841 201318721 34 43629
2020-11-13 10-Q FORM 10-Q 0001640334-20-002809 000-55413 201312504 34 3348727 1
2020-08-14 10-Q FORM 10-Q 0001640334-20-002131 000-55413 201103359 34 2983731 1
2020-05-15 10-Q FORM 10-Q 0001640334-20-001244 000-55413 20884835 34 2235822 1
2020-03-30 10-K FORM 10-K 0001640334-20-000672 000-55413 20758351 34 6287245 1
2019-11-14 10-Q g8751.htm 0001165527-19-000195 000-55413 191219762 34 2775202 1
2019-10-18 D xslFormDX01/primary_doc.xml 06b 0001569340-19-000002 021-351394 191157463 33 5901
2019-08-14 10-Q g8734.htm 0001165527-19-000139 000-55413 191025498 34 14939022 1
2019-06-19 10-K/A g8724.htm 0001165527-19-000114 000-55413 19906195 34 276197
2019-05-20 10-Q g8702.htm 0001165527-19-000089 000-55413 19839601 34 2534389 1
2019-05-15 NT 10-Q g8702a.htm 0001165527-19-000074 000-55413 19825978 34 38177
2019-04-19 8-K g8694.htm 5.02 0001165527-19-000053 000-55413 19758029 34 18950
2019-04-01 10-K g8673.htm 0001165527-19-000034 000-55413 19718552 34 7346748 1
2018-11-14 10-Q g8638.htm 0001165527-18-000225 000-55413 181183187 34 2755541 1
2018-10-18 10-Q g8619.htm 0001165527-18-000196 000-55413 181128958 34 2258216 1
2018-10-18 10-Q g8617.htm 0001165527-18-000195 000-55413 181128948 34 2077043 1
2018-07-25 10-Q g8599.htm 0001165527-18-000160 000-55413 18967299 34 2346779 1
2018-07-25 10-Q g8598.htm 0001165527-18-000158 000-55413 18967296 34 2355692 1
2018-07-25 10-Q g8597.htm 0001165527-18-000156 000-55413 18967286 34 2146856 1
2018-07-25 10-K g8593.htm 0001165527-18-000154 000-55413 18967260 34 11910986 1
2017-03-31 NT 10-K g8393.txt 0001165527-17-000068 000-55413 17728486 34 6105
2016-11-18 10-Q g8331a.htm 0001165527-16-000940 000-55413 162006710 34 3197090 1
2016-11-15 NT 10-Q g8331.txt 0001165527-16-000934 000-55413 161998755 34 6424
2016-08-15 10-Q g8280.htm 0001165527-16-000871 000-55413 161834078 34 3108854 1
2016-05-13 10-Q g8224.htm 0001165527-16-000772 000-55413 161647220 34 2715710 1
2016-04-14 10-K g8190a.htm 0001165527-16-000733 000-55413 161571160 34 8477021 1
2016-04-14 4 PRIMARY DOCUMENT 0001165527-16-000731 5118
2016-04-14 4 PRIMARY DOCUMENT 0001165527-16-000730 5012
2016-03-31 NT 10-K g8190.txt 0001165527-16-000717 000-55413 161541896 34 6405
2015-11-16 10-Q g8076.htm 0001165527-15-000550 000-55413 151233205 34 3529522 1
2015-11-16 8-K g8081.htm 8.01,9.01 0001165527-15-000545 000-55413 151231701 34 1011180
2015-11-13 D xslFormDX01/primary_doc.xml 06b 0001165527-15-000543 021-251213 151228550 33 8438
2015-11-05 8-K g8064.htm 8.01,9.01 0001165527-15-000524 000-55413 151198966 34 54867
2015-08-19 8-K g7981.htm 5.02,9.01 0001165527-15-000418 000-55413 151063437 34 49223
2015-08-11 10-Q g7955.htm 0001165527-15-000396 000-55413 151044629 34 3207571 1
2015-07-28 D xslFormDX01/primary_doc.xml 06b 0001165527-15-000372 021-244580 151009377 33 9217
2015-07-28 8-K g7944.htm 1.01,3.02,9.01 0001165527-15-000365 000-55413 151008474 34 240323
2015-07-22 4 PRIMARY DOCUMENT 0001165527-15-000355 5072
2015-06-10 8-K FORM 8-K 1.01,9.01 0001144204-15-036460 000-55413 15923410 34 58496
2015-06-03 D xslFormDX01/primary_doc.xml 06b 0001144204-15-035251 021-241060 15910160 33 9081
2015-06-03 8-K FORM 8-K 1.01,2.03,3.02,9.01 0001144204-15-035198 000-55413 15909015 34 101423
2015-05-28 8-K FORM 8-K 7.01,9.01 0001144204-15-033887 000-55413 15893958 34 3397414
2015-05-13 10-Q EXHIBIT 10-Q 0001144204-15-030147 000-55413 15858480 34 3491413 1
2015-04-01 3 OWNERSHIP DOCUMENT 0001144204-15-020501 3585
2015-04-01 3 OWNERSHIP DOCUMENT 0001144204-15-020499 3638
2015-04-01 3 OWNERSHIP DOCUMENT 0001144204-15-020496 5333
2015-04-01 3 OWNERSHIP DOCUMENT 0001144204-15-020495 4661
2015-04-01 3 OWNERSHIP DOCUMENT 0001144204-15-020490 4689
2015-04-01 8-A12G FORM 8-A12G 0001144204-15-020469 000-55413 15742401 34 16899
2015-04-01 8-K FORM 8-K 2.03,3.02,9.01 0001144204-15-020440 333-187049 15742014 34 93219
2015-03-13 10-K 10-K 0001144204-15-015954 333-187049 15699466 34 7017650 1
2014-12-02 8-K FORM 8-K 2.03,9.01 0001144204-14-071793 333-187049 141259870 34 28765
2014-11-14 10-Q FORM 10-Q 0001144204-14-068370 333-187049 141221702 34 3606805 1
2014-11-12 424B3 424B3 0001144204-14-067089 333-197972 141213426 33 2656132
2014-11-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2014-11-10 15:00:00 9999999995-14-003291 333-197972 141210593 33 1787
2014-11-07 CORRESP filename1.htm 0001144204-14-065943 10943
2014-10-24 CORRESP filename1.htm 0001144204-14-062838 50084
2014-10-24 S-1/A AMENDMENT TO FORM S-1 0001144204-14-062830 333-197972 141172552 33 8432758 1
2014-10-09 UPLOAD filename1.pdf 0000000000-14-050686 163739
2014-09-23 S-1/A FORM S-1/A 0001144204-14-057412 333-197972 141116657 33 8575323 1
2014-09-23 CORRESP filename1.htm 0001144204-14-057405 111446
2014-09-05 UPLOAD filename1.pdf 0000000000-14-044606 232221
2014-08-19 10-Q FORM 10-Q 0001144204-14-051396 333-187049 141052502 34 3396054 1
2014-08-15 NT 10-Q NT 10-Q 0001144204-14-050538 333-187049 141045423 34 20814
2014-08-08 S-1 FORM S-1 0001144204-14-047983 333-197972 141026572 33 6620454 1
2014-07-01 8-K FORM 8-K 1.01,2.01,3.02,4.01,5.01,5.02,5.06,5.07,9.01 0001144204-14-040712 333-187049 14952233 34 28659848
2014-06-30 8-K CURRENT REPORT DATED 6-27-14 1.01,3.02,9.01 0001165527-14-000391 333-187049 14949962 34 62667
2014-06-26 8-K CURRENT REPORT DATED 6-23-14 5.03,5.07,9.01 0001165527-14-000387 333-187049 14943404 34 6992
2014-06-06 8-K CURRENT REPORT DATED 5-7-14 5.03,5.07,9.01 0001165527-14-000350 333-187049 14897365 34 8522
2014-04-25 10-Q g7378.txt 0001165527-14-000249 333-187049 14784835 34 599163 1
2014-03-25 10-K g7318.txt 0001165527-14-000161 333-187049 14714137 34 1194015 1
2013-11-12 10-Q g7145.txt 0001165527-13-000938 333-187049 131209639 34 563994 1
2013-09-18 424B2 FINAL PROSPECTUS OF TICKET TO SEE INC. 0001165527-13-000810 333-187049 131103582 33 168295
2013-09-17 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2013-09-17 09:00:00 9999999995-13-002680 333-187049 131102526 33 1713
2013-09-13 CORRESP filename1.txt 0001165527-13-000793 2885
2013-09-06 CORRESP filename1.txt 0001165527-13-000789 2889
2013-09-06 S-1/A AMENDMENT NO. 6 TO FORM S-1 0001165527-13-000788 333-187049 131082385 33 190051
2013-08-26 CORRESP filename1.txt 0001165527-13-000766 2888
2013-08-20 S-1/A AMENDMENT NO. 5 TO FORM S-1 0001165527-13-000754 333-187049 131050759 33 193422
2013-08-13 CORRESP filename1.txt 0001165527-13-000699 2883
2013-08-06 S-1/A AMENDMENT NO. 4 TO FORM S-1 0001165527-13-000685 333-187049 131012315 33 195008
2013-07-25 UPLOAD filename1.pdf 0000000000-13-040900 136739
2013-07-15 S-1/A AMENDMENT NO. 3 TO FORM S-1 0001165527-13-000622 333-187049 13967120 33 199982
2013-06-20 UPLOAD filename1.pdf 0000000000-13-033803 151135
2013-06-10 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001165527-13-000543 333-187049 13903720 33 203902
2013-05-23 UPLOAD filename1.pdf 0000000000-13-028571 154215
2013-05-10 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001165527-13-000453 333-187049 13834428 33 213024
2013-03-29 UPLOAD filename1.pdf 0000000000-13-017075 202967
2013-03-05 S-1 FORM S-1 OF TICKET TO SEE INC. 0001165527-13-000223 333-187049 13665317 33 431216

Latest XBRL company facts

One latest value per concept from companyfacts (358 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 67.95M 2026-05-13 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0.001 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
dei EntityPublicFloat Entity Public Float USD 25,625 2024-06-30 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 201,824 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 955,584 2016-09-30 2016 Q3 10-Q 2016-11-18 0001165527-16-000940
us-gaap AccountsPayableAndAccruedLiabilitiesNoncurrent Accounts Payable and Accrued Liabilities, Noncurrent USD 4,474 2015-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.93M 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 105,333 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap AccretionOfDiscount Accretion of Discount (Deprecated 2016-01-31) USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001144204-15-015954
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 660,863 2019-12-31 2019 FY 10-K 2020-03-30 0001640334-20-000672
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 34,788 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 199,444 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap AccruedInsuranceCurrent Accrued Insurance, Current USD 310,157 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.49M 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap AccruedLiabilitiesFairValueDisclosure Accrued Liabilities, Fair Value Disclosure USD 136,439 2018-09-30 2018 Q3 10-Q 2018-11-14 0001165527-18-000225
us-gaap AccruedPayrollTaxesCurrentAndNoncurrent Accrued Payroll Taxes USD 34,714 2014-09-30 2014 Q3 10-Q 2014-11-14 0001144204-14-068370
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 719,028 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 80,999 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030147
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 169,936 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 95,002 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap AccumulatedAmortizationDeferredFinanceCosts Accumulated Amortization, Debt Issuance Costs USD 125,443 2016-06-30 2016 Q2 10-Q 2016-08-15 0001165527-16-000871
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2,582 2018-12-31 2018 FY 10-K 2019-04-01 0001165527-19-000034
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 27.48M 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 16.57M 2020-06-30 2020 Q2 10-Q 2020-08-14 0001640334-20-002131
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 78,791 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD 352,248 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 40,167 2023-01-01 2023-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition USD 3,909 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 79,972 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-12-08 0001493152-22-034876
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 100,600 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 141,672 2023-01-01 2023-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap AdvancesToAffiliate Advances to Affiliate USD 375,500 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap AggregateIndebtedness Aggregate Indebtedness (Deprecated 2019-01-31) USD 2.97M 2018-09-30 2018 Q3 10-Q 2018-11-14 0001165527-18-000225
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 104,475 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 136,356 2022-01-01 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 46,068 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001165527-16-000733
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 361,692 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001493152-23-040079
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 69.86M 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap Assets Assets USD 292,446 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap AssetsCurrent Assets, Current USD 313,767 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap Cash Cash USD 1,240 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 21,993 2023-06-30 2023 Q2 10-Q 2023-09-19 0001493152-23-033011
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 217,211 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1,240 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 23 2024-03-31 2024 Q1 10-Q 2024-07-29 0001493152-24-029448
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -73,391 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 88,298 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 26,828 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001640334-20-002809
us-gaap ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments USD -19,941 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001165527-15-000550
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.75 2023-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 1.50M 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 247,500 2023-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 6.10M 2019-12-31 2019 FY 10-K 2020-03-30 0001640334-20-000672
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 3.51M 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 45.04M 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 45.04M 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap CommonStockValue Common Stock, Value, Issued USD 45,038 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap CompensatedAbsencesLiability Compensated Absences Liability USD 37,500 2018-12-31 2018 FY 10-K 2019-04-01 0001165527-19-000034
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 1,750 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 87,675 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-12-08 0001493152-22-034876
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 233,333 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001165527-16-000733
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 908,311 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 310,000 2013-11-11 2014 FY 10-K 2015-03-13 0001144204-15-015954
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 6.08M 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 43,668 2015-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 908,311 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 3.42M 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap ConvertibleSubordinatedDebtNoncurrent Convertible Subordinated Debt, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 1.55M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-12-02 0001493152-22-034255
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 4.89M 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 210,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-13 0001144204-15-015954
us-gaap DebtConversionOriginalDebtInterestRateOfDebt Debt Conversion, Original Debt, Interest Rate of Debt pure 0.06 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-13 0001144204-15-015954
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 3.50M 2021-06-30 2021 Q2 10-Q 2021-08-12 0001493152-21-019491
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 315,200 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-13 0001144204-15-015954
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.75 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap DebtInstrumentConvertibleNumberOfEquityInstruments Debt Instrument, Convertible, Number of Equity Instruments pure 100,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030147
us-gaap DebtInstrumentConvertibleStockPriceTrigger Debt Instrument, Convertible, Stock Price Trigger USD/shares 2.5 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030147
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD 49,983 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001493152-21-019491
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 250,000 2019-01-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001144204-15-015954
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.08 2020-12-01 2020-12-15 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.1 2016-06-30 2016 Q2 10-Q 2016-08-15 0001165527-16-000871
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 1.55M 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 0 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap DebtInstrumentUnamortizedDiscountPremiumNet Debt Instrument, Unamortized Discount (Premium), Net USD 8,200 2018-12-05 2018 FY 10-K 2019-04-01 0001165527-19-000034
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 1.09M 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 124,650 2015-12-31 2015 FY 10-K 2016-04-14 0001165527-16-000733
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -787,495 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD -1.54M 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 20,000 2016-09-30 2016 Q3 10-Q 2016-11-18 0001165527-16-000940
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 11,665 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -1.26M 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -487,497 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 13.01M 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 1.27M 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 10.75M 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 1.52M 2018-12-31 2018 FY 10-K 2019-04-01 0001165527-19-000034
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 4.94M 2014-12-31 2014 FY 10-K 2015-03-13 0001144204-15-015954
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 240,000 2014-12-31 2014 FY 10-K 2015-03-13 0001144204-15-015954
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 69,337 2020-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 612,808 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 379,270 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 13.01M 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap DepositLiabilitiesAccruedInterest Deposit Liabilities, Accrued Interest USD 12,554 2017-09-30 2017 Q3 10-Q 2018-07-25 0001165527-18-000160
us-gaap Depreciation Depreciation USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001165527-19-000034
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 730,200 2014-06-27 2015 FY 10-K 2016-04-14 0001165527-16-000733
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 5,800 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-07-29 0001493152-24-029448
us-gaap DerivativeLiabilities Derivative Liability USD 351,900 2019-12-31 2020 Q2 10-Q 2020-08-14 0001640334-20-002131
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 32,300 2024-03-31 2024 Q1 10-Q 2024-07-29 0001493152-24-029448
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 42,572 2014-03-31 2014 Q1 10-Q 2014-04-25 0001165527-14-000249
us-gaap DividendsCommonStockPaidinkind Dividends, Common Stock, Paid-in-kind USD 132,173 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap DividendsPaidinkind Dividends, Paid-in-kind USD 323,484 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001165527-18-000225
us-gaap DividendsPayableCurrent Dividends Payable, Current USD 359,453 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 328,614 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 905,975 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap DividendsPreferredStockCash Dividends, Preferred Stock, Cash USD 240,559 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap DividendsPreferredStockPaidinkind Dividends, Preferred Stock, Paid-in-kind USD 1.21M 2023-01-01 2023-12-31 2023 FY 10-K 2024-06-24 0001493152-24-024903
us-gaap DividendsPreferredStockStock Dividends, Preferred Stock, Stock USD -534,919 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap DividendsSharebasedCompensationStock Dividend, Share-based Payment Arrangement, Shares USD 825,100 2019-07-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.04 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.19 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.04 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.28 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.047 2022-01-01 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.002 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.012 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001165527-19-000034
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.031 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0.132 2022-01-01 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.119 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.009 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingenciesDomestic Effective Income Tax Rate Reconciliation, Tax Contingency, Domestic, Percent pure 0.003 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001640334-20-000672
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlements Effective Income Tax Rate Reconciliation, Tax Settlement, Percent pure 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001165527-16-000733
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 9,750 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 79,262 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 5,864 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap ExcessStockSharesAuthorized Excess Stock, Shares Authorized shares 200.00M 2014-05-07 2015 FY 10-K 2016-04-14 0001165527-16-000733
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 49,718 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028675
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 11,235 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) USD 33,786 2022-07-01 2022-09-30 2022 Q3 10-Q 2022-12-08 0001493152-22-034876
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2017-01-01 2017-09-30 2017 Q3 10-Q 2018-07-25 0001165527-18-000160
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 1.1 2017-01-01 2017-09-30 2017 Q3 10-Q 2018-07-25 0001165527-18-000160
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.018 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-13 0001144204-15-015954
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 40,167 2023-01-01 2023-12-31 2023 FY 10-K 2024-06-24 0001493152-24-024903
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD -80,882 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-07-29 0001493152-24-029448
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 372,496 2024-03-31 2024 Q1 10-Q 2024-07-29 0001493152-24-029448
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues USD 45,105 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-18 0001165527-16-000940
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) USD -85,667 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001165527-19-000139
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs USD 577,965 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 314,985 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 20,000 2024-01-01 2024-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 423,839 2018-09-30 2018 Q3 10-Q 2018-11-14 0001165527-18-000225
us-gaap ForeignCurrencyExchangeRateTranslation1 Foreign Currency Exchange Rate, Translation pure 1 2014-12-31 2014 FY 10-K 2015-03-13 0001144204-15-015954
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 2,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001165527-16-000733
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD 16,977 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028675
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD -126,400 2023-01-01 2023-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 17,893 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost USD 93,750 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 483,404 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -2.29M 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -4.12M 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -4.51M 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -391,396 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -4.56M 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001640334-20-002809
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 949 2023-01-01 2023-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 430,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 1.26M 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 40,494 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 492,501 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-20 0001165527-19-000089
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 153,994 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-09-19 0001493152-23-033011
us-gaap IncreaseDecreaseInDeferredCompensation Increase (Decrease) in Deferred Compensation USD 24,670 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -152,932 2015-01-01 2015-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 16,977 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001640334-20-002809
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 93,752 2017-01-01 2017-06-30 2017 Q2 10-Q 2018-07-25 0001165527-18-000158
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 82,279 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-09-19 0001493152-23-033011
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 3,367 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 285 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -80,375 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028675
us-gaap IncrementalCommonSharesAttributableToWrittenPutOptions Incremental Common Shares Attributable to Dilutive Effect of Written Put Options shares 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-19 0001144204-14-051396
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 15,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-13 0001144204-15-015954
us-gaap InterestExpense Interest Expense USD 111,725 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-12-02 0001493152-22-034255
us-gaap InterestExpenseBorrowings Interest Expense, Borrowings USD 177,970 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap InterestExpenseDebt Interest Expense, Debt USD 629,201 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap InterestExpenseOther Interest Expense, Other USD 170,868 2022-01-01 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 69,849 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028675
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -124,774 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001165527-18-000225
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001640334-20-002809
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 70,379 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap InterestPayableCurrent Interest Payable, Current USD 117,000 2024-05-31 2024 Q3 10-Q 2024-11-14 0001493152-24-045964
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 199,151 2020-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap InvestmentIncomeAmortizationOfDiscount Investment Income, Amortization of Discount USD 10,095 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 905,641 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap Liabilities Liabilities USD 20.43M 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 292,446 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap LiabilitiesCurrent Liabilities, Current USD 10.14M 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap LitigationSettlementAmountAwardedFromOtherParty Litigation Settlement, Amount Awarded from Other Party USD 267,680 2019-10-01 2019-10-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 38,838 2023-08-01 2023-08-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap LongTermDebt Long-term Debt USD 50,000 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 113,000 2023-12-31 2024 Q3 10-Q 2024-11-14 0001493152-24-045964
us-gaap LossContingencyDamagesPaidValue Loss Contingency, Damages Paid, Value USD 146,912 2022-04-01 2022-06-30 2022 Q3 10-Q 2022-12-08 0001493152-22-034876
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 267,680 2019-10-01 2019-10-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 527,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 550,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-10-18 0001165527-18-000195
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -2,582 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001144204-14-068370
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -2,582 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001165527-16-000733
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -600,391 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -405,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-20 0001165527-19-000089
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -1.48M 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -1.83M 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap NoncontrollingInterestInNetIncomeLossPreferredUnitHoldersNonredeemable Noncontrolling Interest in Net Income (Loss) Preferred Unit Holders, Nonredeemable USD 240,559 2017-01-01 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -483,264 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap NotesPayable Notes Payable USD 1.41M 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap NotesPayableCurrent Notes Payable, Current USD 768,126 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 150,000 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap NumberOfOperatingSegments Number of Operating Segments Segments 1 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap NumberOfReportableSegments Number of Reportable Segments Segments 1 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001144204-15-015954
us-gaap OperatingExpenses Operating Expenses USD 998,587 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -998,587 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 22.60M 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 36,062 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 32,535 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030147
us-gaap OtherAssetsCurrent Other Assets, Current USD 1,404 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 99,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 67,200 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 225,500 2020-09-30 2020 Q3 10-Q 2020-11-13 0001640334-20-002809
us-gaap OtherNoncashExpense Other Noncash Expense USD 102,355 2022-01-01 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 135,924 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -561,821 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 33,400 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001640334-20-002809
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 6,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 20,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 55,150 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001165527-16-000733
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 2,582 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001165527-16-000733
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD -327,626 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001165527-18-000225
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 352,248 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2016-09-30 2016 Q3 10-Q 2016-11-18 0001165527-16-000940
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2016-09-30 2016 Q3 10-Q 2016-11-18 0001165527-16-000940
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 1,342 2021-03-31 2021 Q1 10-Q 2021-05-17 0001493152-21-011971
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 80,375 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 200,000 2021-06-30 2021 Q2 10-Q 2021-08-12 0001493152-21-019491
us-gaap ProceedsFromCollectionOfAdvanceToAffiliate Proceeds from Collection of Advance to Affiliate USD 500,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001165527-18-000225
us-gaap ProceedsFromCollectionOfLongtermLoansToRelatedParties Proceeds from Collection of Long-term Loans to Related Parties USD 100,000 2015-01-01 2015-01-31 2016 Q2 10-Q 2016-08-15 0001165527-16-000871
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 794,960 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-09-19 0001493152-23-033011
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 71,400 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001165527-16-000733
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 728,347 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 100,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 1.22M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap ProceedsFromIssuanceOfSeniorLongTermDebt Proceeds from Issuance of Senior Long-term Debt USD 575,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001493152-21-019491
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 500,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-17 0001493152-21-011971
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 603,355 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-14 0001640334-20-002131
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 30,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-06-24 0001493152-24-024903
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 114,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 350,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-09-19 0001493152-23-033011
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 159,375 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1,995 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap ProductWarrantyExpense Product Warranty Expense USD -283,500 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001640334-20-000672
us-gaap ProfessionalFees Professional Fees USD 39,965 2012-06-06 2014-03-31 2014 Q1 10-Q 2014-04-25 0001165527-14-000249
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -1.29M 2022-04-01 2022-06-30 2022 Q2 10-Q 2022-12-02 0001493152-22-034255
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 192 2017-03-31 2017 Q1 10-Q 2018-07-25 0001165527-18-000156
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 83,333 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 75,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 146,912 2022-01-01 2022-12-31 2023 FY 10-K 2024-06-24 0001493152-24-024903
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 60,500 2021-01-01 2021-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 146,912 2022-01-01 2022-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap RepaymentsOfSubordinatedDebt Repayments of Subordinated Debt USD -68,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-15 0001640334-20-001244
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 1.94M 2022-01-01 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap RestrictedCash Restricted Cash USD 3,500 2021-06-30 2022 Q2 10-Q 2022-12-02 0001493152-22-034255
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 93,095 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 3,500 2020-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap RestructuringReserveTranslationAdjustment Restructuring Reserve, Foreign Currency Translation Gain (Loss) USD 14,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -47.66M 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 0.34 2023-09-30 2023 Q3 10-Q 2023-11-09 0001493152-23-040079
us-gaap SalesRevenueServicesNet Sales Revenue, Services, Net (Deprecated 2018-01-31) USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030147
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 985,037 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001165527-19-000195
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 309,297 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045964
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 815,490 2015-09-30 2015 Q3 10-Q 2015-11-16 0001165527-15-000550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030147
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030147
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 2.21M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001165527-15-000550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.75 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001640334-20-000672
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 10.72M 2015-09-30 2015 Q3 10-Q 2015-11-16 0001165527-15-000550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 0.61 2015-09-30 2015 Q3 10-Q 2015-11-16 0001165527-15-000550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030147
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030147
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001640334-20-000672
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.1 2019-01-01 2019-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.017 2019-01-01 2019-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 221,275 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations shares 85,000 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 5.42M 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 20.77M 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030147
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 6.93M 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.83 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares -1.42M 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 500,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 1 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 5.33M 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 85,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001640334-20-000672
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 750,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.1 2022-01-01 2022-12-31 2023 FY 10-K 2024-06-24 0001493152-24-024903
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.93M 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.83 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 2,540 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001493152-21-019491
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 5,405 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001493152-21-019491
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0.75 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1 2022-01-01 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 1.25 2020-12-15 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 0.001 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap SharePrice Share Price USD/shares 0.75 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 1 2022-09-13 2023 FY 10-K 2024-06-24 0001493152-24-024903
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 249,713 2020-07-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001640334-20-002809
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationGross Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture USD 40,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -20.14M 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap StockIssued1 Stock Issued USD 1.39M 2024-01-01 2024-12-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 281,697 2017-01-20 2017-10-03 2018 FY 10-K 2019-04-01 0001165527-19-000034
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 183,095 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001493152-23-040079
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 360,000 2022-08-01 2022-08-31 2024 FY 10-K 2026-04-07 0001493152-26-015359
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 4.83M 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 188,125 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 71,400 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001165527-16-000733
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 520 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-07-29 0001493152-24-029448
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 62,252 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001493152-23-040079
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 19,900 2024-01-01 2024-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 520 2024-01-01 2024-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 260,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 74,600 2022-01-01 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 356,510 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-15 0001640334-21-000923
us-gaap SupplementalDeferredPurchasePrice Supplemental Deferred Purchase Price USD 100,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001165527-15-000550
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2022-12-31 2022 FY 10-K 2023-08-08 0001493152-23-027069
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 717,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001165527-19-000034
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 508,915 2017-12-31 2017 FY 10-K 2018-07-25 0001165527-18-000154
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 6.86M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-19 0001144204-14-051396
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 45.04M 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 33.12M 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010133
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 2.04M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030147
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 45.04M 2025-01-01 2025-03-31 2025 Q1 10-Q 2026-05-14 0001493152-26-022926

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →